Introduce our readers to R5 Capital by telling us a bit about the business overall. Mr. Mushkin: R5 Capital is a consumer research and consulting firm. It was formed roughly five and a half years ago.

Let’s start with an introduction of sorts to CS McKee — your overall business, portfolios, and investment approach — before we get into a specific fund. Mr. Thompson: At CS McKee, we’re primarily an ...

Let’s start with an overview of the Global High Dividend Low Volatility Fund (NAWGX) that you manage — a high-level snapshot of what the portfolio looks like and what the key elements or ...

I thought a good place to start would be with you, Craig, telling our readers a bit about Icon Advisers, the company overall and what the business looks like today. It’s almost 40 years ago that you ...

For our readers, let’s start with some introductory information about Phocas Financial, an overview of the firm’s history and what the business looks like today. Ms. Foreman: Phocas is an ...

The Wall Street Transcript is a completely unique resource for investors and business researchers.

Alan H. Auerbach has served as Chairman of the Board and as CEO and President of Puma Biotechnology, Inc. since its inception. Before joining Puma, Mr. Auerbach served as Founder, CEO, President ...

Steven M. Lichtman is Managing Director and Senior Analyst for medical devices at Oppenheimer & Co. Inc. Mr. Lichtman has been on the sell side following the medical devices sector for over 20 ...

Jason Wittes is a Managing Director and Senior Research Analyst at Roth Capital Partners. He has over 20 years of health care investment experience on both the buy side and sell side. Prior to ...

Vlad Vitoc, M.D., is Chairman of Board, Chief Executive Officer, and President of MAIA Biotechnology Inc. Dr. Vitoc has a broad array of experience across commercial strategic analysis and ...

Erez Aminov is the Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc., a biopharmaceutical company developing treatments for neuropsychiatric disorders. In addition, Mr. Aminov ...

Ilan Sobel has been the CEO of BioHarvest Sciences Inc. since July 2020. He brought the company’s first product, VINIA, to North America, building a direct-to-consumer machine that is now ...